To identify lncRNA potentially involved in Notch-induced GSC maintenance, we further performed lncRNA microarray analysis in GSCs with either treatment by small interfering RNA (siRNA) targeting Notch1 (si-Notch1), si-JAG1 (Notch ligand)25, or γ-secretase inhibitors (N-S-phenyl-glycine-t-butyl ester (DAPT) and RO4929097, which is undergoing clinical trial in glioma) (Supplementary Data 1). The gene discussed is JAG1; the disease is central nervous system cancer.